从自然界取得标的物是否具有可专利性是个颇具争议的问题。2013年,美国分子病理学会诉Myriad基因公司案的判决结果引起各方解读,并促使美国专利商标局颁布了对涉及自然法则、自然现象和自然产品的可专利性判断的审查指南。文章通过对自然界取得的标的物授予专利权的判断标准分析,阐明专利制度对利益诉求的平衡作用和价值指向。
Patentability of claims reciting or involving natural world(i.e.laws of nature/natural principles,natural phenomena,and natural products)is a controversial issue. A case titled Association for Molecular Pathology v.Myriad Genetics,Inc.triggered worldwide discussion in2013,which prompted United Sates Patent and Trademark Office to issue the guidance titled Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature,Natural Phenomena Natural Products.By analyzing the acceptability criteria for patentability of subject matter reciting or involving the natural world,this paper argues that the significance of patent institution lies in balancing the various demands of pursuit and orientating value judgement.